Skip to main content

Chameleon Biosciences is developing a better way to treat rare genetic diseases

This Berkeley startup is mimicking the way tumors replicate in the body so that patients with rare diseases can get better outcomes from gene therapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.